Adults undergoing catheter ablation for atrial fibrillation in the TriNetX network were grouped by use of a GLP-1 drug, an SGLT2 inhibitor or both. Recurrence after the three-month blanking period was similar in all three matched comparisons. All-cause mortality was lower on the combination, with hazard ratios of 0.54 against a GLP-1 drug alone and 0.60 against an SGLT2 inhibitor alone.
Why it is interesting: The arrhythmia outcome shows no difference, yet mortality does, on wide intervals in routine records.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.